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UROGENITAL 
 
The Diagnostic Accuracy of 
Abdominal Ultrasound Imaging for 
Detection of Ovarian Masses  
Background/Objective: Detection of the tissue diagnosis of ovarian space occupying lesions 
(OSOL) has remained a challenging task for sonographers since many adnexal masses have 
nonspecific sonographic appearances. Our objective was to evaluate the accuracy of the ab-
dominal sonographic diagnosis of adnexal masses in 79 women with a known OSOL under-
going laparotomy for ovarian masses in Tabriz Alzahra's Haspital, northwestern Iran. 
Patients and Methods: From March 2004 to February 2005, sonographic reports of each pa-
tient were compared with postoperative findings. 
Results: Comparison of the preoperative sonographic and final pathologic diagnoses revealed 
a correct sonographic diagnosis in 77% of patients. The identification of ovarian cystic tera-
toma was correct in 17/24 cases (sensitivity of 71% and specificity of 98%). The identification 
of ovarian malignancy was correct in 7/10 patients (sensitivity of 70% and specificity of 
98.5%). Sonograms were frankly misread in 14/79 cases, and were missed in 4/79 cases. 
Conclusion: In conclusion, our results show high resolution abdominal ultrasonography is an 
effective method in diagnosis of ovarian tumors and on 70% of patients can differentiate 
malignant tumors from benign tumors. 
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Introduction 
varian cancer is now the fourth leading cause of cancer death in the United 
States, with more than 14,000 deaths being reported each year.1 adnexal 
lesion characterization (benign vs malignant) is essential for proper patient eval-
uation and treatment decisions. 
Ultrasound is the primary imaging modality to evaluate the ovaries, with a re-
ported accuracy of up to 94% for diagnosis of malignancy.2 Assessment with ul-
trasound has been shown to be a sensitive but relatively nonspecific method, 
leading to unnecessary surgical resection of many benign lesions.3 
The differential diagnosis of adnexal masses, including their benign or malig-
nant nature, plays a major role in defining the appropriate surgical strategy, 
which in the case of malignancy allows for a longer disease-free period and even 
cure. This would also permit the use of laparoscopy in selected cases. 
The use of methods such as various types of ultrasound has been reported to at-
tain higher preoperative diagnostic accuracy.4 Traditionally, sonologists have de-
pended on masses size and morphology as features distinguishing between be-
nign and malignant lesions.5 Over the last few years, new diagnostic techniques 
have made a significant contribution to the diagnosis of adnexal masses and in 
selecting the best surgical treatment. 
The majority of ovarian masses are benign (80%), with cystic, solid or mixed 
characteristics and a favorable prognosis. The other 20% of these masses are ma-
lignant tumors.  
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Considering that the lifetime risk of developing an 
ovarian tumor is around 5%–7%, diagnostic means 
are needed which permit accurate classification of 
these ovarian masses before surgery. Unfortunately, 
the available diagnostic modalities do not allow dis-
tinction between benign ovarian tumors and malig-
nant tumors. In the majority of cases, this is only es-
tablished by histologic study of the surgical specimen. 
It is now well established that histopathology is the 
gold standard for diagnosis of ovarian mass.6,7 
The objective of the present approach was to assess 
the sensitivity, specificity, and positive and negative 
predictive values of abdominal sonographic imaging 
for discriminating ovarian masses. 
Patients and Methods 
We reviewed records of 107 patients who were 
hospitalized for surgical treatment of known ovarian 
space occupying lesions (OSOL) between March 2004 
and February 2005 within the Department of Ultra-
sound at Alzahra Hospital, Tabriz, northwestern Iran. 
Patients who had not exact records of sonographic 
and pathologic reports excluded from the study. 
All ultrasound examinations were performed by a 
dedicated sinologist with 15 years of experience using 
a General Electric Model X200 ultrasound unit with 
3.5 MHz abdominal probe. 
Pathologic reports were reviewed by a pathologist 
with 10 years of experience. Pathologic reports were 
obtained from laparotomy biopsy specimens for all 
patients. The excised masses were classified patholog-
ically in two groups of benign and malignant. 
Comparison of the preoperative sonographic and fi-
nal pathologic diagnoses was performed and data was 
analyzed. The sensitivity, specificity and positive and 
negative predictive values were determined for ab-
dominal sonographic assessment, for predicting the 
presence of malignancy and the most common ova-
rian masses.  
Results 
Seventy-nine patients had both sonographic and pa-
thologic reports. The mean age of participants was 47 
(range: 17–62) years. The pathologic diagnoses of the 
ovarian masses removed are presented in Table 1. 
Pathologically, there were 69 benign and 10 malig-
nant ovarian lesions. The most common diagnosis 
made by pathology was cystic teratoma followed by 
serous cystadenoma and mucinous cystadenoma. 
Findings at pathology showed cystic teratoma (der-
moid) in 24 of 79 patients. 
The sensitivity of sonography for ovarian cystic te-
ratoma was 71% (CI95%: 53%–89%), the specificity 
was 98%, the positive predictive value (PPV) was 
94%, the negative predictive value (NPV) was 88.5%, 
the positive likelihood ratio (LR+) was 39.4, and the 
negative likelihood ratio (LR-) was 0.29. 
According to pathologic reports, the rate of a malig-
nant condition was 10 in 79 patients. Seven of 10 ova-
rian cancers were correctly identified by ultrasound. 
Malignant ovarian tumors were distinguished from 
other lesions with a sensitivity of 70% (CI95%: 42%–
98%), a specificity of 98.5%, a PPV of 87.5%, a NPV 
of 96%, an LR+ of 46.7 and an LR- of 0.3. 
Sonographic findings were different from patholog-
ic findings in 18 of 79 patients, including four pa-
tients in whom the ovarian mass was missed in sono-
graphy while pathology indicated lesions in ovaries; 
in 14 patients the sonography reports were inconsis-
tence with pathologic findings. A correct sonographic 
diagnosis was obtained in 61 of 79 patients yielding a 
sensitivity of 77% (CI95%: 68%–86%). 
Discussion 
The ovaries are solid, slightly nodular, almond-
shaped organs lying deep in the pelvis. Their hidden 
location, plus the fact that their size, shape, position, 
and histology change over a woman's lifetime, help 
explain why ovarian cancer is not readily detected in 
early stages.8 
Most ovarian masses detected by ultrasound are be-
nign. It is essential that ultrasound images are inter-
preted in a manner that decreases inter-observer var-
iations and false-positive results. Patients with clini-
cal findings suggestive for ovarian tumor should un-
dergo transvaginal and/or transabdominal sonogra-
phy. Sonographic morphology indexing should be 
performed according to a consensus. The single find-
ing most suggestive for malignancy is a solid or papil-
lary component extending from the inner wall of the 
tumor.9 
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The author's experience is that absence of solid 
components and absence of irregularities in an ad-
nexal mass at ultrasound examination suggests a be-
nign lesion, whereas any irregularity wehether it is in 
the outline, the cyst wall, or in the echogenicity of a 
tumor suggests malignancy.10 Ultrasound images rep-
resentative of benign and malignant extra-uterine 
pelvic tumors are shown in Figure 1. 
A correct diagnosis of adnexal masses is relevant to 
making a suitable pre- and intra-operative therapeu-
tic decision, which decreases the risk of finding un-
diagnosed carcinomas in laparoscopic and conven-
tional surgeries.4 
Sonography (transvaginal and transabdominal) is a 
sensitive method for detecting ovarian cancer, al-
though it lacks the accuracy required to prevent sur-
gery in those who raise no suspicion. In spite of pro-
viding low levels of false negative results, hence good 
degree of diagnosing benign lesions, the false positive 
rate is high.11-14 
Campbell et al. first used transabdominal ultrasono-
graphy for evaluation of ovarian cancer in asympto-
matic patients. In their study, transabdominal ultra-
sound had a sensitivity of 100%, a specificity of 
97.7%, and a positive predictive value of 1.5%. They 
concluded that transabdominal ultrasound is not ef-
fective in discriminating benign from malignant cys-
tic tumors, and hence, is less suitable for evaluation of 
ovarian tumors than transvaginal ultrasonography.15 
The introduction of transvaginal ultrasound has sig-
nificantly improved the ability to look in detail at 
pelvic structures.16 Recent studies have indicated that 
transvaginal ultrasound has a positive predictive val-
ue of only 10% in postmenopausal women. This 
means that for every ovarian cancer identified, at 
least 10 benign ovarian tumors will be detected.12, 17 
Ultrasound pelvic examination is a harmless and 
non-invasive procedure and is the most commonly-
used procedure to determine the origin, contents (sol-
id or liquid) and volume of the neoplasm. When poss-
ible, transvaginal ultrasound is preferable; its sensitiv-
ity of around 100% and specificity of around 83% is 
higher than the transabdominal ultrasound which has 
a specificity and sensitivity of over 80%.18, 19 
Our study showed that abdominal sonography had a 
sensitivity of 70% and a specificity of 98.55% for pre-
dicting ovarian cancer. Sassone et al. indicated that 
the sensitivity of transvaginal ultrasound is around 
100; its specificity is around 83% which is higher 
than the transabdominal ultrasound which has a sen-
sitivity and specificity of over 80%.12, 19 An initial re-
port by Kurjak et al. found a sensitivity and specifici-
ty about 100% and 99%, respectively, in predicting 
ovarian cancer.20 Bourne et al. and Finkler et al. indi-
cated combining advanced ultrasound and measure-
ment of serum CA 125 significantly can effectively 
detect early ovarian cancer and decrease mortality 
rate for ovarian cancer.21, 22 
Most dermoid cysts are easily recognized at grey-
scale imaging owing to their fat and hair content. 
However, as many as 9% or even 18% of dermoid 
cysts, may manifest a predominately cystic echo pat-
tern indistinguishable from that of other cystic 
masses. The most characteristic ultrasound features of 
a dermoid cyst are the presence of (1) a “white ball” 
(corresponding to hair and sebum) in the corner of a 
cysts, or filling up the whole tumor, (2) long, echo-
genic (white) lines and prominent echogenic dots in 
cyst fluid (corresponding to hair floating freely in 
Table 1. Pathologic findings in patients (n=79) 
Benign  Malignant  
Cystic teratoma 
Serous cystadenoma 
Mucinous cystadenoma 
Sertoli cell tumor 
Others 
24 
22 
11 
2 
10 
Mucinous cystadenocarcinoma 
Serous cystadenocarcinoma 
Papillary serous cystadenocarcinoma 
Mullerian mixed tumor 
Others  
3 
2 
1 
1 
3 
Table 2. Comparison of results as assessed by pathology and sono-
graphy 
               Pathology 
Sonography 
Positive Negative Total 
Positive 17 1 18 
Negative 7 54 61 
Total 24 55 79 
Note. Sensitivity (TP/TP+FN) =71%. Specificity (TN/TN+FP) =98%. Positive predictive value 
(TP/TP+FP) = 94%. Negative predictive value (TN/TN+FN) =88.5%. Positive likelihood ratio 
(sensitivity/1-specificity) =39.4. Negative likelihood ratio (1-sensitivity/specificity) = o.29 
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non-fatty fluid), and (3) shadowing. Typical ultra-
sound images of cystic teratoma are shown in Figure 
2. 
Confusion of dermoid cysts with mucinous cystade-
noma and serous cystadenoma has been reported.10 In 
this approach cystic teratoma was the most common 
diagnosed lesion by ultrasonography. Sensitivity and 
specificity obtained were 71%, 98%, respectively. 
Marret indicated that transvaginal sonography has 
demonstrated considerable advantage over conven-
tional transabdominal sonography. However, trans-
abdominal sonography is still useful in large tumors. 
Also Marret showed that the ultrasound and morpho-
logic parameters have a sensitivity of 80% and a spe-
cificity of 93% which make this examination the gold 
standard for ovarian cysts diagnosis.23 
At present, several parameters are available for dis-
tinguishing benign from malignant masses. The gray-
scale two-dimensional sonographic parameters that 
are used most frequently are tumor diameter or vo-
lume, septation and presence of papillary projections, 
echogenicity, and the presence of free fluid. The 
blood flow of ovarian tumor can be evaluated by B-
mode color Doppler ultrasonography and waveform 
analysis. The resistance to flow is lower in malignant 
than in benign tumors. Frequently used Doppler pa-
rameters are resistance index, pulsatility index, and 
peak systolic velocity. To improve the preoperative 
assessment of adnexal masses, most of these parame-
ters have been combined with patient characteristics 
in diagnostic models. Although the initial publication 
reported an almost perfect performance of these 
models, external validation showed their diagnostic 
performance to be less than good.24 
Color flow Doppler technique combined with ultra-
sound are useful for more precise classification of the 
mass by studying its vascularity. In the benign tu-
mors, vascularization is normal and in malignant tu-
mors, neovascularization is evident.7 
The authors concluded that sonography could not 
differentiate follicular cysts, serous cysts and mucin-
ous cysts very well, however, because benign cysts 
could form or resolve within 24 hours, sonography is 
immediately suggested before operation. This pre-
vents unnecessary laparotomy and its complications. 
Improved ovarian visualization via diagnostic imag-
ing technologies is critical for the early detection of 
asymptomatic lesions of the ovary which should de-
crease the number of inappropriate operative inter-
ventions. 
In conclusion, our results show high resolution ab-
dominal ultrasonography is an effective method in 
diagnosis of ovarian tumors and on 70% of patients 
can differentiate malignant tumors from benign tu-
mors. 
Fig 2. Teratoma cyst with (A) typical "white ball", (B) typical long
echogenic lines and bright prominent spots representing hair in fluid
and, (C) typical shadowing. 
Fig 1. Left: Benign tumor characterized by absence of solid com-
ponents and absence of irregularities. Right: Malignant tumor cha-
racterized by presence of solid components and presence of irregu-
larities. 
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